SPDR S&P Pharmaceuticals ETF Rating $43.17 +0.63 (+1.48%) Closing price 04:10 PM EasternExtended Trading$43.13 -0.04 (-0.09%) As of 04:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy 2.71Holdings in XPH have an aggregate rating of Moderate Buy based on 242 analyst ratings issued in the past year covering 25 companies (78.8% of the portfolio).XPH Aggregate Price Target$43.17High Prediction$43.17Average Prediction$43.17Low Prediction$43.17Holdings in XPH have an aggregate price target of $43.17 and a range of $43.17 to $43.17 covering 25 companies (78.8% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 XPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.98%RPRXRoyalty Pharma$37.58+1.5%4.9334 of 5 stars3.25$49.00 30.4%4Earnings Report3.80%ELANElanco Animal Health$16.61+0.8%3.3331 of 5 stars2.88$16.33 -1.7%8Trending NewsEarnings ReportAnalyst Forecast3.78%AXSMAxsome Therapeutics$104.80+0.5%4.8018 of 5 stars3.07$178.00 69.8%15Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision3.77%JAZZJazz Pharmaceuticals$111.30-0.7%4.2988 of 5 stars2.93$181.43 63.0%14Trending NewsEarnings ReportAnalyst Forecast3.77%MRKMerck & Co., Inc.$80.73+0.4%4.9978 of 5 stars2.35$107.44 33.1%20Positive News3.73%PFEPfizer$24.57+1.4%4.9867 of 5 stars2.39$28.12 14.4%18Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision3.72%CORTCorcept Therapeutics$72.30+1.1%4.6431 of 5 stars3.00$134.50 86.0%5Insider Trade3.71%JNJJohnson & Johnson$173.40+1.1%4.6842 of 5 stars2.65$174.50 0.6%20Positive News3.69%VTRSViatris$9.70+3.3%2.5378 of 5 stars1.80$10.40 7.2%5News CoverageEarnings ReportDividend AnnouncementShort Interest ↑High Trading Volume3.67%PRGOPerrigo$22.62-0.9%4.6293 of 5 stars2.40$33.00 45.9%5Trending NewsEarnings ReportAnalyst ForecastHigh Trading Volume3.66%TARSTarsus Pharmaceuticals$47.85-0.2%2.5196 of 5 stars3.00$66.67 39.3%7News CoverageEarnings ReportAnalyst Revision3.54%LLYEli Lilly and Company$625.15-2.5%4.9874 of 5 stars2.68$990.89 58.5%22Trending NewsEarnings ReportAnalyst DowngradeInsider TradeGap UpHigh Trading Volume3.52%OGNOrganon & Co.$9.22+1.2%4.8705 of 5 stars2.50$18.00 95.2%6Earnings ReportDividend Announcement3.44%BMYBristol Myers Squibb$45.96+1.3%4.6169 of 5 stars2.24$56.38 22.7%21Positive NewsAnalyst Downgrade3.41%ZTSZoetis$147.34-0.6%4.8062 of 5 stars2.70$204.63 38.9%10Positive NewsEarnings ReportAnalyst Revision3.28%PBHPrestige Consumer Healthcare$65.61-3.0%4.545 of 5 stars2.50$93.33 42.3%6Trending NewsEarnings ReportAnalyst Forecast2.96%HRMYHarmony Biosciences$34.194.695 of 5 stars3.00$51.00 49.2%10Earnings ReportAnalyst Revision2.40%PCRXPacira BioSciences$25.18+5.9%3.0325 of 5 stars2.44$25.75 2.3%9Earnings Report2.32%OCULOcular Therapeutix$12.21-0.7%3.7825 of 5 stars3.00$17.20 40.9%5News CoverageEarnings ReportAnalyst ForecastAnalyst Revision2.29%ANIPANI Pharmaceuticals$81.48+18.1%3.2214 of 5 stars3.00$83.25 2.2%9Trending NewsEarnings ReportAnalyst ForecastGap UpHigh Trading Volume2.19%AMRXAMNEAL PHARMACEUTICALS$8.54+4.0%3.6294 of 5 stars3.00$11.60 35.8%5Earnings Report2.14%XERSXeris Biopharma$6.84+3.6%3.0253 of 5 stars2.83$6.25 -8.6%6News CoveragePositive NewsEarnings ReportHigh Trading Volume2.11%SUPNSupernus Pharmaceuticals$41.23-0.6%1.8028 of 5 stars2.67$41.00 -0.6%3Analyst ForecastInsider Trade1.97%LGNDLigand Pharmaceuticals$150.06+2.6%3.6483 of 5 stars3.00$157.00 4.6%6News CoverageEarnings ReportAnalyst Forecast1.96%INVAInnoviva$18.34-0.7%4.303 of 5 stars3.00$40.33 119.9%3Positive NewsEarnings ReportAnalyst Revision This page (NYSEARCA:XPH) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
